Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Orexigen Therapeutics Inc

+ Add to Watchlist

OREX:US

5.7900 USD 0.1500 2.66%

As of 20:10:00 ET on 03/02/2015.

Company Profile for Orexigen Therapeutics Inc (OREX)

Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system (CNS) disorders with an initial focus on obesity.

Contact Information

Orexigen Therapeutics Inc

3344 N. Torrey Pines Court
Suite 200
La Jolla, CA 92037
United States
Phone: 1-858-875-8600
Fax: 1-858-875-8650

Key Executives for Orexigen Therapeutics Inc (OREX)

Michael Narachi "Mike"President/CEOMark D BoothChief Commercial Officer
Joseph P Hagan "Jay"Chief Bus Officer/Acting CFOHeather D TurnerSenior VP/Secretary/Gen Cnsl
Preston S KlassenSenior VP:Product Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil